Related Experiment Video
Updated: May 25, 2026
05:26
Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications
Yaping Hou1, Junli Hu, Hyejin Park
1Division of Advanced Prosthodontics, Biomaterials and Hospital Dentistry, University of California, Los Angeles, California 90095, USA.
Journal of Biomedical Materials Research. Part A
|January 26, 2012
Summary
Chitosan/tripolyphosphate/chondroitin sulfate nanoparticles offer controlled protein release for tissue engineering. Researchers optimized particle composition for sustained release and maintained protein bioactivity.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Tissue Engineering
Background:
- Controlled protein delivery is crucial for tissue regeneration.
- Osteogenic proteins like Nel-like molecule-1 (Nell-1) show promise for bone repair.
- Developing effective carriers for these proteins is essential for therapeutic applications.
Purpose of the Study:
- To prepare chitosan/tripolyphosphate/chondroitin sulfate (Chi/TPP/CS) nanoparticles for controlled protein release.
- To investigate the effect of particle composition on protein encapsulation and release kinetics.
- To evaluate the suitability of these nanoparticles for tissue engineering scaffolds.
Main Methods:
- Nanoparticles were synthesized using an ionic gelation method.
- The osteogenic protein Nel-like molecule-1 (Nell-1) was used as a model protein.
- Protein-loaded nanoparticles were incorporated into collagen hydrogels and PLGA scaffolds.
Main Results:
- Particle composition influenced protein association and release rates.
- Increased crosslinking agents (TPP and CS) resulted in sustained protein release.
- Protein bioactivity was preserved, and nanoparticles integrated well into scaffolds without compromising structural integrity.
Conclusions:
- Chi/TPP/CS nanoparticles are effective carriers for sustained protein delivery.
- These nanoparticles show potential for tissue engineering applications.
- Further in vivo evaluation is warranted to confirm therapeutic efficacy.
